Research suggests that intranasal nanosuspensions offer a promising way to formulate and deliver drugs that are poorly soluble in water to patients with chronic conditions.
Rajasekhar Jaladi, PhD
Advertisement
Rajasekhar Jaladi, PhD, [email protected] is associate vice president, drug metabolism and pharmacokinetics, for proprietary products, at Dr. Reddy’s.
Articles by Rajasekhar Jaladi, PhD
Advertisement
Latest Updated Articles
Assessment of Nanosuspension Formulation for Intranasal AdministrationSeptember 2nd 2020
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Viral Safety 2.0: Plant-Ready Actions for ICH Q5A(R2) Compliance
2
Leveraging an Innovative Mid-Scale Manufacturing Solution to Meet Diverse Needs
3
Faster Doesn’t Mean Easier: Development Impacts of a New Biosimilar Regulatory Landscape
4
A Pharma Manufacturing Blueprint from Delaware’s Innovation Vision
5